ClearPoint Neuro, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Inventory

Note 3 - Inventory

3 Months Ended

Mar. 31, 2015

Notes to Financial Statements

Inventory Disclosure [Text Block]

Inventory

Inventory consists of the following as of:

	March 31		December 31,
	2015		2014
Raw materials and work in process	$	1,028,258	$	899,014
Software license inventory		350,000		350,000
Finished goods		718,641		716,025
Inventory included in current assets		2,096,899		1,965,039
Software license inventory		892,500		910,000
	$	2,989,399	$	2,875,039

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References + Details